XML 124 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes
12 Months Ended
Jan. 03, 2015
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES

U.S. and foreign income from operations before income taxes are as follows (in thousands):

        
 
January 3, 2015
 
December 28, 2013
 
December 29, 2012
United States
$
58,972

 
$
174,470

 
$
206,785

Foreign
22,480

 
(10,792
)
 

Income from operations before income taxes
$
81,452

 
$
163,678

 
$
206,785



Income tax expense attributable to income from continuing operations before income taxes consists of the following (in thousands):

         
 
January 3, 2015
 
December 28, 2013
 
December 29, 2012
Current:
 
 
 
 
 
Federal
$
1,134

 
$
8,109

 
$
54,982

State
(884
)
 
7,213

 
10,368

Foreign
24,770

 
482

 
58

Total current
25,020

 
15,804

 
65,408

Deferred:
 

 
 

 
 
Federal
886

 
40,396

 
10,015

State
1,235

 
505

 
592

Foreign
(14,000
)
 
(1,994
)
 

Total deferred
(11,879
)
 
38,907

 
10,607

 
$
13,141

 
$
54,711

 
$
76,015



Income tax expense for the years ended January 3, 2015, December 28, 2013 and December 29, 2012, differed from the amount computed by applying the statutory U.S. federal income tax rate to income from continuing operations before income taxes as a result of the following (in thousands):

        
 
January 3, 2015
 
December 28, 2013
 
December 29, 2012
Computed "expected" tax expense
$
28,508

 
$
57,287

 
$
72,375

State income taxes, net of federal benefit
228

 
5,017

 
7,124

Section 199 qualified domestic production deduction

 
(619
)
 
(4,830
)
Change in valuation allowance
5,420

 
507

 
254

Non-deductible compensation expenses
1,622

 
106

 
253

Deferred tax on unremitted foreign earnings
1,956

 

 

Sub-Part F income
3,786

 

 

Foreign rate differential
(9,754
)
 
694

 

Biofuel tax incentives
(22,546
)
 
(9,342
)
 

Non-deductible transaction costs
4,107

 
996

 

Other, net
(186
)
 
65

 
839

 
$
13,141

 
$
54,711

 
$
76,015



The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at January 3, 2015 and December 28, 2013 are presented below (in thousands):

        
 
January 3, 2015
 
December 28, 2013
Deferred tax assets:
 
 
 
Loss contingency reserves
$
11,500

 
$
10,756

Employee benefits
11,866

 
9,749

Pension liability
20,106

 
4,183

Intangible assets amortization, including taxable goodwill
3,300

 
7,040

Net operating losses
75,920

 
4,732

Inventory
7,965

 
2,120

Other
11,130

 
7,186

Total gross deferred tax assets
141,787

 
45,766

Less valuation allowance
(18,037
)
 
(871
)
Net deferred tax assets
123,750

 
44,895

 
 
 
 
Deferred tax liabilities:
 
 
 
Intangible assets amortization, including taxable goodwill
(189,877
)
 
(63,779
)
Property, plant and equipment depreciation
(203,602
)
 
(67,535
)
Investment in DGD Joint Venture
(41,040
)
 
(31,842
)
Tax on unremitted foreign earnings
(47,870
)
 

Other
(3,368
)
 
(3,209
)
Total gross deferred tax liabilities
(485,757
)
 
(166,365
)
Net deferred tax liability
$
(362,007
)
 
$
(121,470
)
 
 
 
 
Amounts reported on Consolidated Balance Sheets:
 
 
 
Current deferred tax asset
$
45,001

 
$
17,289

Current deferred tax liability
(642
)
 

Non-current deferred tax asset
16,431

 

Non-current deferred tax liability
(422,797
)
 
(138,759
)
Net deferred tax liability
$
(362,007
)
 
$
(121,470
)

     
At January 3, 2015 and December 28, 2013, the Company had net deferred tax liabilities of approximately $362.0 million and $121.5 million, respectively. The increase in the deferred tax liability is principally due to deferred tax liabilities resulting from the carryover basis in the VION Acquisition, which was a stock acquisition.

At January 3, 2015, the Company had net operating loss carryforwards for federal income tax purposes of approximately $82.4 million, which begin to expire in 2019.  As a result of the change in ownership which occurred pursuant to the May 2002 recapitalization, utilization of approximately $4.9 million of the federal net operating loss carryforwards is limited to approximately $0.7 million per year for the remaining life of the net operating losses. The Company had approximately $48.5 million of net operating loss carryforwards for state income tax purposes, which begin to expire in 2015. Also at January 3, 2015, the Company had U.S. foreign tax credit carryforwards of approximately $0.9 million and state tax credit carryforwards of approximately $0.8 million. The Company had foreign net operating loss carryforwards of about $153.2 million, $55.1 million of which expire in 2015 through 2033 and $98.1 million of which can be carried forward indefinitely. As of January 3, 2015, the Company had a valuation allowance of $1.7 million due to uncertainties in respect to its ability to utilize its U.S. foreign tax credit carryforwards and U.S. state tax credit carryforwards before they expire. The Company also had a valuation allowance of $16.3 million due to uncertainties in its ability to utilize foreign net operating loss carryforwards and other foreign deferred tax assets.

At January 3, 2015, the Company had unrecognized tax benefits of approximately $8.1 million. During the year, the Company's unrecognized tax benefits increased by $7.4 million primarily related to recording unrecognized tax benefits from the VION Acquisition and the TRS Transaction in purchase accounting. An indemnity receivable of $6.5 million has also been recorded in respect to the VION Acquisition. There was no material income statement activity in fiscal 2014 in respect to unrecognized tax benefits. All of the unrecognized tax benefits would favorably impact the Company's effective tax rate if recognized. The Company believes it is reasonably possible that unrecognized tax benefits could change by $2.2 million in the next twelve months. The possible change in unrecognized tax benefits relates to the expiration of certain statutes of limitation and the possible settlement of an ongoing income tax audit. The Company recognizes accrued interest and penalties, as appropriate, related to unrecognized tax benefits as a component of income tax expense. As of January 3, 2015, interest and penalties related to unrecognized tax benefits were $2.5 million. These interest and penalties related to the unrecognized tax benefits from the Vion Acquisition and were primarily recorded in purchase accounting.

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):

 
January 3, 2015
 
December 28, 2013
Balance at beginning of Year
$
652

 
$

Change in tax positions related to current year

 
652

Change in tax positions related to prior years
7,935

 

Expiration of the Statute of Limitations
(457
)
 

Balance at end of year
$
8,130

 
$
652



In fiscal 2014, the Company's major taxing jurisdictions are U.S. (federal and state), Belgium, Brazil, Canada, China, France, Germany and the Netherlands. The Company is subject to regular examination by various tax authorities and although the final outcome of these examinations is not yet determinable, the Company does not anticipate that any of the examinations will have a significant impact on the Company's results of operations or financial position. The statute of limitations for the Company's major jurisdictions is open for varying periods, but is generally closed through the 2005 tax year.

Prior to fiscal 2014, the Company did not have significant operations outside of the U.S. During fiscal 2013, the Company began operations in Canada through the Rothsay Acquisition. During fiscal 2014, the Company began operations in the other major taxing jurisdictions through the VION Acquisition. The Company expects to indefinitely reinvest the earnings of its foreign subsidiaries outside the U.S. and has generally not provided deferred income taxes on the accumulated earnings of its foreign subsidiaries. At January 3, 2015, the amount of foreign subsidiary earnings indefinitely reinvested outside of the U.S. for which no deferred incomes taxes have been provided is not significant.